Wang Bao-Cheng, Ma Jie
Department of Pediatric Neurosurgery, Xinhua Hospital, Shanghai JiaoTong University, Shanghai 200092, China.
Chin Med J (Engl). 2015 May 5;128(9):1238-44. doi: 10.4103/0366-6999.156141.
This overview seeked to bring together the microRNA (miRNA) researches on biogenesis and bio-function in these areas of clinical diagnosis and therapy for malignant glioma.
Using the keyword terms "glioma" and "miRNA," we performed the literature search in PubMed, Ovid, and web.metstr.com databases from their inception to October 2014.
In screening out the quality of the articles, factors such as clinical setting of the study, the size of clinical samples were taken into consideration. Animal studied for verification and reviews article were also included in our data collection.
Despite many advance in miRNA for malignant glioma, further studies were still required to focus on the following aspects: (i) Improving the understanding about biogenesis of miRNA and up-down regulation; (ii) utilizing high-throughput miRNA expression analysis to screen out the core miRNA for glioma; (iii) Focusing related miRNAs on the signal transduction pathways that regulate the proliferation and growth of glioma.
We discussed the most promising miRNA, correlative signaling pathway and their relation with gliomas in the way of prompting miRNA target into being a clinical therapeutic strategy.
本综述旨在汇总恶性胶质瘤临床诊断与治疗领域中有关微小RNA(miRNA)生物合成及生物学功能的研究。
使用关键词“胶质瘤”和“miRNA”,在PubMed、Ovid以及web.metstr.com数据库中进行文献检索,检索时间跨度从各数据库建库至2014年10月。
在筛选文章质量时,考虑了研究的临床背景、临床样本规模等因素。用于验证的动物研究及综述文章也纳入了我们的数据收集范围。
尽管miRNA在恶性胶质瘤研究方面取得了诸多进展,但仍需进一步研究关注以下方面:(i)加深对miRNA生物合成及上调和下调调控的理解;(ii)利用高通量miRNA表达分析筛选出胶质瘤的核心miRNA;(iii)聚焦与调节胶质瘤增殖和生长的信号转导通路相关的miRNA。
我们以促使miRNA靶点成为临床治疗策略的方式,讨论了最具前景的miRNA、相关信号通路及其与胶质瘤的关系。